Sacituzumab govitecan may be an effective treatment for heavily pre-treated HR+/HER2- metastatic breast cancer.
1. Median progression-free survival was longer in the SG group than in the chemotherapy group. 2. Median overall survival was...
1. Median progression-free survival was longer in the SG group than in the chemotherapy group. 2. Median overall survival was...
1. There was no difference in median overall survival between minimal follow-up and CT-based follow-up groups. 2. Disease-free survival was...
1. A high risk of incident lung cancer exists for smokers that do not meet low-dose computed tomography screening criteria....
1. All cancer types had the greatest decrease in screening during the early part of the pandemic. 2. Europe had...
1. No significant difference in pCR, DFS, or OS was found for subgroup analysis of ERBB2-0 vs. ERBB2-low tumours 2....
1. The pathologic response rate was similar in the atezolizumab treatment group as compared to placebo. 2. There were more...
1. The rate of progression was 57% lower in the group receiving anal HSIL treatment as compared to the group...
1. Median overall survival is longer for HER2-low breast cancer patients receiving trastuzumab deruxtecan compared with other chemotherapy treatment options....
1. Reduced median overall survival associated with annual rate of change in circulating tumour cell (CTC) abundance >0.12 CTCs/mL 2....
1. Disease-free survival did not differ significantly between patient groups and overall survival at 3 years was the same for...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.